Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 129   

Articles published

VRX 146.06 +3.06 (2.14%)
price chart
Valeant Pharmaceuticals International Inc to drop deal-making for now to cut ...
NEW YORK/WINNIPEG - Valeant Pharmaceuticals International Inc is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt, boost its stock price and one day return to its traditional deal-making in a stronger position ...
Why Slashing Debt Is Important For Valeant Pharmaceuticals Intl Inc (VRX)?  InvestCorrectly
Related articles »  
Why Valeant Pharmaceuticals Intl Inc. and Allergan Inc. Would Be Better Together
Valeant Pharmaceuticals Intl Inc.(TSX: VRX)(NYSE: VRX) and Pershing Square Capital Management LP submitted a hostile bid for Allergan Inc. (NYSE: AGN) months ago, but any potential for a deal appeared dead after both sides exchanged barbs.
Allergan Ups Earnings Guidance Amid Takeover Battle With Valeant  Bidness ETC
Allergan, Inc Up As Deutsche Bank Initiates Coverage With Buy Rating  Benzinga
Related articles »  
Valeant Pharmaceuticals International Inc shares pummelled on lower 2014 ...
Canada's Valeant Pharmaceuticals International Inc, embroiled in a bitter battle to take over Botox-maker Allergan Inc, on Thursday cut its 2014 and 2015 profit forecasts, sending shares almost 7% lower.
Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results  MarketWatch
Allergan Sues Valeant Claiming Insider Scheme With Ackman  Bloomberg
Related articles »  
Actavis plans new merger approach for Allergan Inc as Valeant Pharmaceuticals ...
Allergan, which has repeatedly rejected offers from Valeant Pharmaceuticals International Inc, would consider a takeover proposal that values the company at above $200 per share, some of these people said.
Latest Strategy in Valeant Pharmaceuticals Intl Inc (VRX) -Pershing ...  StockWise Daily
Valeant, Pershing Square to Boost Allergan Bid  Wall Street Journal
Related articles »  
2 Reasons to Avoid Valeant Pharmaceuticals Intl Inc, and 1 Stock to Buy Instead
In Canada, few companies are able to seriously compete on the global stage. But Valeant Pharmaceuticals Intl Inc (TSX: VRX)(NYSE: VRX) is one of them, and has become one of the country's big success stories.
Making Sense of the Valeant Pharmaceuticals International Inc. and Allergan ...
There's a lot of posturing and name-calling going on between Valeant Pharmaceuticals International Inc. (TSX:VRX)(NYSE:VRX) and Allergan, Inc. (NYSE:AGN).
Allergan Gets Into Trouble As Confidential Documents Are Unsealed  Bidness ETC
Most Critical Documents Supporting Allergan, Valeant  ValueWalk
Related articles »  
Company Watch: Valeant Pharmaceuticals Intl Inc (NYSE:VRX)
[The Fly] After meeting with Valeant Pharmaceuticals Intl Inc (NYSE:VRX) management, RBC Capital has �a constructive view� of the company's 2015 guidance, and thinks the company's organic growth will be favorable over the next two to three years.
Valeant Pharmaceuticals Intl Receives BUY Rating from BMO Capital Markets ...  Intercooler
Related articles »  
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Onexton Gets Approval
[Zacks] Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares gained 1.5% immediately on news that the company's Onexton Gel, 1.2%/3.75% has been approved by the FDA for the once-daily treatment of patients (12 years and above) suffering from acne ...
Valeant Pharmaceuticals Intl Inc (VRX), Actavis plc (ACT), Clovis Oncology ...  StockWise Daily
Valeant Pharmaceuticals Intl Director Buys $218595 in Stock (VRX)  Ticker Report
Related articles »  
Valeant Pharmaceuticals Intl Inc (VRX): ValueAct Keeps Its Promise and Buys ...
In a new filing with the Securities and Exchange Commission, Jeff Ubben's ValueAct Capital reported increasing its position in Valeant Pharmaceuticals Intl Inc (NYSE:VRX). The fund has acquired 210,000 shares in one transaction at a price of $142.25 ...
Valeant Pharmaceuticals Intl Inc (VRX) announces redemption of $445.0 ...  InvestCorrectly
Valeant Pharmaceuticals Intl Given Average Recommendation of "Buy" ...  sleekmoney
Related articles »  
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Chimes in on Allergan ...
[PR Newswire] Valeant Pharmaceuticals Intl Inc (NYSE:VRX) today commented on the announcement that Allergan, Inc. (AGN) and Actavis plc (NYSE: ACT) have entered into a definitive agreement under which Actavis will acquire all outstanding shares of ...
Stymied by Actavis-Allergan deal, Valeant looks for another M&A  The Globe and Mail
Actavis to Buy Allergan for $66 Billion, Topping Valeant Bid  Businessweek
Related articles »